Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.23.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Nov. 30, 2023
Nov. 30, 2022
Operating Activities    
Net (loss) earnings $ 17,738 $ 7,453
Net (Loss) Earnings from Discontinued Operations (567) 1,044
Net Earnings from Continuing Operations 18,305 6,409
Impairment & divestiture (benefits) charges 147 0
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 3,426 4,193
Stock-based compensation expense 2,717 2,155
Benefit for deferred income taxes (24) (33)
Amortization of debt issuance costs 146 460
Other Noncash Income (Expense) 1,527 11
Changes in components of working capital and other, excluding acquisitions and divestitures:    
Accounts receivable 2,517 9,844
Inventories (4,590) (5,684)
Trade accounts payable (4,984) 2,130
Prepaid expenses and other assets (9,089) (8,377)
Income tax accounts 1,051 5,104
Accrued compensation and benefits (11,154) 1,529
Other accrued liabilities (3,912) 73
Cash provided by (used in) operating activities, Continuing Operations (3,917) 17,814
Cash (used in) provided by operating activities, Discontinued Operations (2,758) (281)
Cash (Used in) Provided By Operating Activities (6,675) 17,533
Investing Activities    
Capital expenditures (1,567) (2,535)
Cash used in investing activities, Continuing Operations (2,594) (2,535)
Cash Provided by Investing Activities (2,594) (2,535)
Financing Activities    
Borrowings on Revolving Credit 39,000 14,000
Principal Repayment on Revolving Credit Facility (8,000) (11,000)
Principal repayments on term loan (625) 0
Taxes paid related to the net share settlement of equity awards (2,081) (969)
Stock option exercises & other 2,317 972
Cash dividend (2,178) (2,274)
Net Cash Used in Financing Activities, Continuing Operations 2,317 (5,688)
Cash used in financing activities 2,317 (5,688)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (6,459) 8,544
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations 493 (766)
Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less 0 (4,000)
Payments of Debt Issuance Costs 0 (2,417)
Payments for Repurchase of Common Stock (26,116) 0
Proceeds from Issuance of Term Loan 0 200,000
Payment for redemption of term loan 0 (200,000)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents 147,956 129,243
Purchase of assets $ (1,027) $ 0